Clinical Research Directory

Inclusion Criteria: * Lebanese adult with obesity (≥18 years), obesity being defined as BMI ≥ 30 kg/m2 * Patients who can commit to frequent visit trials as per study protocol * Patients not traveling outside Lebanon for at least the 6-month period of the trial * Patients tolerating Metformin after a run-in period of 2 weeks Exclusion Criteria: * Patients who have taken other weight reducing drug therapy in the previous 6 months * Patients who have undergone bariatric therapy or endoscopic procedure, or planning to do so in the near future (at \< 6 months) * Patients with diabetes * Patients working at AUB-MC, as we will not be able to assess the adherence to study visits nor the feasibility of such a program in the general population, presenting to AUB-MC only for clinical care * A family member of a patient already enrolled in the study, as the participants will not be independent * Pregnant obese patients * Patients with pacemakers * Patients known to have hypertension, cardiac, pulmonary, renal or liver disease, active cancer or psychiatric illnesses * History of any surgery of less than 6 weeks duration * Patients known to have disabling osteoarthritic or orthopedic problems * Patients secondary uncontrolled endocrine disorders (thyroid disorders, polycystic ovary, Cushing disease), or drug induced obesity (such as anti-psychotic, steroids, hormonal therapy).